BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gohar F, Kessel C, Lavric M, Holzinger D, Foell D. Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks? Arthritis Res Ther 2016;18:163. [PMID: 27411444 DOI: 10.1186/s13075-016-1069-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Yeo JG, Ng CT, Albani S. Precision medicine in pediatric rheumatology. Current Opinion in Rheumatology 2017;29:500-5. [DOI: 10.1097/bor.0000000000000419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Rosina S, Natoli V, Santaniello S, Trincianti C, Consolaro A, Ravelli A. Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis. Expert Rev Clin Immunol 2021;17:853-70. [PMID: 34139935 DOI: 10.1080/1744666X.2021.1945441] [Reference Citation Analysis]
3 Smolewska E. Are we closer to personalized therapy in juvenile idiopathic arthritis? Reumatologia 2016;54:151-2. [PMID: 27826167 DOI: 10.5114/reum.2016.62467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Choida V, Hall-Craggs M, Jebson BR, Fisher C, Leandro M, Wedderburn LR, Ciurtin C. Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis. Front Pharmacol 2020;11:635823. [PMID: 33603671 DOI: 10.3389/fphar.2020.635823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Park C, Miranda-Garcia M, Berendes R, Horneff G, Kuemmerle-Deschner J, Ganser G, Huppertz HI, Minden K, Haas JP, Jansson AF, Borte M, Schuetz C, Oommen P, Frosch M, Schlueter B, Richter-Unruh A, Kessel C, Hinze C, Wittkowski H, Roth J, Foell D, Holzinger D. MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever. Rheumatology (Oxford) 2021:keab729. [PMID: 34559193 DOI: 10.1093/rheumatology/keab729] [Reference Citation Analysis]
6 Yang CA, Chiang BL. Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge. Clin Rev Allergy Immunol 2021;61:156-70. [PMID: 33236284 DOI: 10.1007/s12016-020-08825-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, Rieber N, Hufnagel M, Jansson AF, Hedrich C, Winowski H, Berger T, Foeldvari I, Ganser G, Hospach A, Huppertz HI, Mönkemöller K, Neudorf U, Weißbarth-Riedel E, Wittkowski H, Horneff G, Foell D; PRO-KIND SJIA project collaborators. Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany. Pediatr Rheumatol Online J 2018;16:7. [PMID: 29357887 DOI: 10.1186/s12969-018-0224-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
8 Jamilloux Y, Georgin-Lavialle S, Sève P, Belot A, Fautrel B. [It is time to reconcile systemic juvenile idiopathic arthritis and adult-onset Still's disease]. Rev Med Interne 2019;40:635-6. [PMID: 31221454 DOI: 10.1016/j.revmed.2019.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Gohar F, Windschall D. The new role of musculoskeletal ultrasound in the treat-to-target management of juvenile idiopathic arthritis. Rheumatology (Oxford) 2021;60:2046-53. [PMID: 33493330 DOI: 10.1093/rheumatology/keab004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Margheri F, Laurenzana A, Giani T, Maggi L, Cosmi L, Annunziato F, Cimaz R, Del Rosso M. The protease systems and their pathogenic role in juvenile idiopathic arthritis. Autoimmun Rev 2019;18:761-6. [PMID: 31181328 DOI: 10.1016/j.autrev.2019.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ter Haar NM, Jansen MHA, Frenkel JF, Vastert SJ. How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases. Clin Immunol 2020;219:108538. [PMID: 32681980 DOI: 10.1016/j.clim.2020.108538] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ruscitti P, Conforti A, Pavlych V, Giacomelli R. Inhibiting inflammatory cytokines in adult onset Still’s disease. Current trends and new therapeutic perspectives. Expert Opinion on Orphan Drugs 2019;7:547-54. [DOI: 10.1080/21678707.2019.1701431] [Reference Citation Analysis]
13 Ruscitti P, Cipriani P, Di Benedetto P, Liakouli V, Berardicurti O, Carubbi F, Ciccia F, Guggino G, Triolo G, Giacomelli R. H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome. Clin Exp Immunol 2018;191:220-8. [PMID: 28960260 DOI: 10.1111/cei.13057] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
14 Holzinger D, Tenbrock K, Roth J. Alarmins of the S100-Family in Juvenile Autoimmune and Auto-Inflammatory Diseases. Front Immunol 2019;10:182. [PMID: 30828327 DOI: 10.3389/fimmu.2019.00182] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
15 Cai L, Zhang C, Wu J, Zhou W, Chen T. Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis. Clin Immunol 2021;229:108800. [PMID: 34289424 DOI: 10.1016/j.clim.2021.108800] [Reference Citation Analysis]
16 Mitrovic S, Fautrel B. New Markers for Adult-Onset Still's Disease. Joint Bone Spine 2018;85:285-93. [DOI: 10.1016/j.jbspin.2017.05.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
17 Tibaldi J, Pistorio A, Aldera E, Puzone L, El Miedany Y, Pal P, Giri PP, De H, Khubchandani R, Chavan PP, Vilaiyuk S, Lerkvaleekul B, Yamsuwan J, Sabui TK, Datta P, Pardeo M, Bracaglia C, Sawhney S, Mittal S, Hassan WA, Elderiny GF, Abu-Zaid MH, Eissa M, Sztajnbok F, das Neves Sztajnbok FC, Russo R, Katsicas MM, Cimaz R, Marrani E, Alexeeva E, Dvoryakovskaya TM, Alsuweiti MO, Alzyoud RM, Kostik M, Chikova I, Minoia F, Filocamo G, Farag Y, Lotfy H, Nasef SI, Al-Mayouf SM, Maggio MC, Magalhaes CS, Gallizzi R, Conti G, Shimizu M, Civino A, Felici E, Giancane G, Ruperto N, Consolaro A, Ravelli A. Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 2020;59:3505-14. [PMID: 32829413 DOI: 10.1093/rheumatology/keaa240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
18 Gohar F, Mcardle A, Jones M, Callan N, Hernandez B, Kessel C, Miranda-garcia M, Lavric M, Holzinger D, Pretzer C, Lainka E, Vastert SJ, de Roock S, Fitzgerald O, Pennington SR, Foell D. Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis. Ann Rheum Dis 2019;78:1107-13. [DOI: 10.1136/annrheumdis-2019-215051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Nishimura K, Hara R, Umebayashi H, Takei S, Iwata N, Imagawa T, Shimizu M, Tomiita M, Seko N, Kitawaki T, Yokota S. Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients. Mod Rheumatol 2021;31:226-34. [PMID: 32552266 DOI: 10.1080/14397595.2020.1783163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhang X, Shi S, Shen J, Zhao M, He Q. Functional Immunoregulation by Heme Oxygenase 1 in Juvenile Autoimmune Diseases. Curr Gene Ther 2019;19:110-6. [PMID: 31288720 DOI: 10.2174/1566523219666190710092935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Vastert SJ, Jamilloux Y, Quartier P, Ohlman S, Osterling Koskinen L, Kullenberg T, Franck-Larsson K, Fautrel B, de Benedetti F. Anakinra in children and adults with Still's disease. Rheumatology (Oxford) 2019;58:vi9-vi22. [PMID: 31769856 DOI: 10.1093/rheumatology/kez350] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
22 Yang S, Ohe R, Aung NY, Kato T, Kabasawa T, Utsunomiya A, Takakubo Y, Takagi M, Yamakawa M. Comparative study of HO-1 expressing synovial lining cells between RA and OA. Mod Rheumatol 2021;31:133-40. [PMID: 31829080 DOI: 10.1080/14397595.2019.1704976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Orczyk K, Smolewska E. A Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis. J Immunol Res 2018;2018:5349837. [PMID: 30426025 DOI: 10.1155/2018/5349837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
24 Lipinska J, Kaszkowiak M, Malachowska B, Swidrowska-Jaros J, Smolewska E. Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value-a single-center study. Arthritis Res Ther 2021;23:40. [PMID: 33494811 DOI: 10.1186/s13075-021-02424-y] [Reference Citation Analysis]
25 Hügle B, Schippers A, Fischer N, Ohl K, Denecke B, Ticconi F, Vastert B, Costa IG, Haas JP, Tenbrock K. Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis. Arthritis Res Ther 2018;20:98. [PMID: 29848367 DOI: 10.1186/s13075-018-1603-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
26 Zandstra J, Jongerius I, Kuijpers TW. Future Biomarkers for Infection and Inflammation in Febrile Children. Front Immunol 2021;12:631308. [PMID: 34079538 DOI: 10.3389/fimmu.2021.631308] [Reference Citation Analysis]
27 Garner AJ, Saatchi R, Ward O, Hawley DP. Juvenile Idiopathic Arthritis: A Review of Novel Diagnostic and Monitoring Technologies. Healthcare (Basel) 2021;9:1683. [PMID: 34946409 DOI: 10.3390/healthcare9121683] [Reference Citation Analysis]